A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants-Reference-Cited by-同舟云学术

A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants

Published:2013-09-19 Issue:9 Volume:9 Page:1903-1909
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Eregowda Adarsh,Lalwani Sanjay,Chatterjee Sukanta,Vakil Hoshang,Ahmed Khaleel,Costantini Marco,Lattanzi Maria

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.25166

Reference23 articles.

1. IAP Committee on Immunization 2009-2011. In:Yewale V, Choudhury P,Thacker N, ed(s).IAP guidebook on immunization, Mumbai: Indian Academy of Pediatrics, 2011:1-180.

2. Combination Vaccines for Childhood Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP)

3. Development and introduction of a ready-to-use pediatric pentavalent vaccine to meet and sustain the needs of developing countries – Quinvaxem®: The first 5 years

4. Immunogenicity and safety in infants of a DTwPHib full liquid vaccine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Immunogenicity and Safety of Diphtheria–Tetanus–Pertussis–Hepatitis B–Haemophilus influenza B (Bio Farma) with Pentabio® Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants;Vaccines;2023-02-21

2. Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study;Vaccine: X;2022-12

3. Immunogenicity and Safety of Three WHO Prequalified (DTwP -HB-Hib) Pentavalent Combination Vaccines Administered As Per Iranian National Immunization Plan in Iranian Infants: A Randomized, Phase III Study;Indian Pediatrics;2021-12

4. Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6–8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study;Vaccine;2019-08

5. Hepatitis B s-Antigen Seroconversion Rate After Primary Immunization Series with Newly Introduced Pentavalent Vaccine: A Report of Regional Study in Alborz Province, Iran, 2016;Archives of Pediatric Infectious Diseases;2019-04-13